AltraTech

Executive Summary

AltraTech is an Irish diagnostics company pioneering a dual-modality platform that integrates serology and viral nucleic acid testing into a single, compact device. Founded in 2016 and headquartered in Cork, the company aims to revolutionize point-of-care diagnostics by enabling rapid triage and treatment decisions, accelerating biomarker discovery for drug development, and empowering consumers with home self-testing capabilities. This convergence of immunological and molecular testing in one handheld unit could significantly improve patient outcomes and reduce healthcare costs, particularly in infectious disease management and chronic condition monitoring. While still in early development stages with no disclosed funding or valuation, AltraTech's technology addresses a clear market need for decentralized, accurate, and easy-to-use diagnostic solutions. The company's progress and future milestones will be critical in determining its ability to compete in the rapidly evolving diagnostics landscape.

Upcoming Catalysts (preview)

• TBDCompletion of prototype for integrated serology/nucleic acid device60% success
• TBDInitiation of clinical trial for point-of-care triage application50% success
• TBDStrategic partnership or licensing deal with a larger diagnostics firm40% success